Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

  • Interventional
  • Recruiting
  • NCT05296512

A Phase II Trial of Pembrolizumab and Lenvatinib in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary

This research study is being done to test the efficacy and safety of combining the study drugs pembrolizumab and lenvatinib in patients with clear cell ovarian cancer. The names of the study drugs involved in this study are: - Lenvatinib - Pembrolizumab